A Deep Dive into the Atrial Fibrillation Market's Soaring Projection to $3,370.70 Million by 2030 with a Steady 6.4% CAGR Unveiled in Latest Report
Atrial fibrillation (AFib) stands as a pervasive cardiovascular concern, impacting millions globally. Characterized by irregular and often rapid heartbeats, AFib poses serious health risks, including stroke, heart failure, and blood clots. The Atrial Fibrillation market has witnessed a consistent upward trajectory,...
Source: pharmiweb.com
